In summary, the nestin‐cre MFN2T105M mouse model extends the expression of mutant MFN2 to all cell types, and presents critical phenotypic features of CMT2A patients, such as gait disturbances and reduction in the number of mitochondria in the tibialis muscle. This evidence concerns the gene MFN2 and Charcot-Marie-Tooth disease type 2A1.